In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir
Crossref DOI link: https://doi.org/10.1007/s40121-014-0052-8
Published Online: 2014-12-17
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Friborg, Jacques
Zhou, Nannan
Han, Zhou
Yang, Xiaoyan
Falk, Paul
Mendez, Patricia
McPhee, Fiona